Oscar Aubi Catevilla

Title: Oscar Aubi Catevilla: Innovator in Pharmacological Treatments

Introduction

Oscar Aubi Catevilla is a notable inventor based in Bergen, Norway. He has made significant contributions to the field of pharmacology, particularly in the treatment of metabolic disorders. His innovative work has led to the development of a patent that addresses a critical health issue.

Latest Patents

Oscar Aubi Catevilla holds a patent for a treatment related to hyperphenylalaninemia. The patent, titled "Hyperphenylalaninemia and treatments thereof," involves compounds that act as pharmacological chaperones. These compounds, including trimethoprim and its analogues, stabilize phenylalanine hydroxylase (PAH) for the treatment of hyperphenylalaninemia, especially phenylketonuria (PKU). He has 1 patent registered under his name.

Career Highlights

Throughout his career, Oscar has worked with various organizations that focus on technological advancement and innovation. Notably, he has been associated with Bergen Teknologioverføring AS and Vestlandets Innovasjonsselskap AS. His work in these companies has contributed to the development and commercialization of innovative solutions in the healthcare sector.

Collaborations

Oscar has collaborated with esteemed colleagues, including Lars Skjærven and Knut Teigen. These partnerships have enhanced his research and development efforts, leading to impactful advancements in pharmacological treatments.

Conclusion

Oscar Aubi Catevilla is a distinguished inventor whose work in pharmacological treatments has the potential to improve the lives of individuals affected by metabolic disorders. His innovative contributions continue to shape the future of healthcare solutions.